The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Progenitor Cell Product Market Research Report 2024
Synopsis
Progenitor Cell, also called stem cell, a biological cell that can differentiate into a specific cell type.
The global Progenitor Cell Product market was valued at US$ 13270 million in 2023 and is anticipated to reach US$ 23180 million by 2030, witnessing a CAGR of 9.7% during the forecast period 2024-2030.
Rising development of precision medicine, increasing number of cell therapy production facilities, and increasing number of clinical trials are expected to be the major driving factors for the market. Recent advances in stem cell therapy and tissue engineering have the potential to draw attention to the treatment of a variety of diseases. Moreover, rising demand for stem cell banks and rising research activities related to stem cell production, storage, and characterization are also expected to drive market revenue growth.
This report aims to provide a comprehensive presentation of the global market for Progenitor Cell Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Progenitor Cell Product.
Report Scope
The Progenitor Cell Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Progenitor Cell Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Progenitor Cell Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NeuroNova AB
StemCells
ReNeuron Limited
Asterias Biotherapeutics
Thermo Fisher Scientific
STEMCELL Technologies
Axol Bio
R&D Systems
Lonza
ATCC
Irvine Scientific
CDI
Segment by Type
Pancreatic progenitor cells
Cardiac Progenitor Cells
Intermediate progenitor cells
Neural progenitor cells (NPCs)
Endothelial progenitor cells (EPC)
Others
Segment by Application
Medical care
Hospital
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Progenitor Cell Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Progenitor Cell, also called stem cell, a biological cell that can differentiate into a specific cell type.
The global Progenitor Cell Product market was valued at US$ 13270 million in 2023 and is anticipated to reach US$ 23180 million by 2030, witnessing a CAGR of 9.7% during the forecast period 2024-2030.
Rising development of precision medicine, increasing number of cell therapy production facilities, and increasing number of clinical trials are expected to be the major driving factors for the market. Recent advances in stem cell therapy and tissue engineering have the potential to draw attention to the treatment of a variety of diseases. Moreover, rising demand for stem cell banks and rising research activities related to stem cell production, storage, and characterization are also expected to drive market revenue growth.
This report aims to provide a comprehensive presentation of the global market for Progenitor Cell Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Progenitor Cell Product.
Report Scope
The Progenitor Cell Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Progenitor Cell Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Progenitor Cell Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NeuroNova AB
StemCells
ReNeuron Limited
Asterias Biotherapeutics
Thermo Fisher Scientific
STEMCELL Technologies
Axol Bio
R&D Systems
Lonza
ATCC
Irvine Scientific
CDI
Segment by Type
Pancreatic progenitor cells
Cardiac Progenitor Cells
Intermediate progenitor cells
Neural progenitor cells (NPCs)
Endothelial progenitor cells (EPC)
Others
Segment by Application
Medical care
Hospital
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Progenitor Cell Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Progenitor Cell Product Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pancreatic progenitor cells
1.2.3 Cardiac Progenitor Cells
1.2.4 Intermediate progenitor cells
1.2.5 Neural progenitor cells (NPCs)
1.2.6 Endothelial progenitor cells (EPC)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Progenitor Cell Product Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical care
1.3.3 Hospital
1.3.4 Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Progenitor Cell Product Market Perspective (2019-2030)
2.2 Progenitor Cell Product Growth Trends by Region
2.2.1 Global Progenitor Cell Product Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Progenitor Cell Product Historic Market Size by Region (2019-2024)
2.2.3 Progenitor Cell Product Forecasted Market Size by Region (2025-2030)
2.3 Progenitor Cell Product Market Dynamics
2.3.1 Progenitor Cell Product Industry Trends
2.3.2 Progenitor Cell Product Market Drivers
2.3.3 Progenitor Cell Product Market Challenges
2.3.4 Progenitor Cell Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Progenitor Cell Product Players by Revenue
3.1.1 Global Top Progenitor Cell Product Players by Revenue (2019-2024)
3.1.2 Global Progenitor Cell Product Revenue Market Share by Players (2019-2024)
3.2 Global Progenitor Cell Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Progenitor Cell Product Revenue
3.4 Global Progenitor Cell Product Market Concentration Ratio
3.4.1 Global Progenitor Cell Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Progenitor Cell Product Revenue in 2023
3.5 Progenitor Cell Product Key Players Head office and Area Served
3.6 Key Players Progenitor Cell Product Product Solution and Service
3.7 Date of Enter into Progenitor Cell Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Progenitor Cell Product Breakdown Data by Type
4.1 Global Progenitor Cell Product Historic Market Size by Type (2019-2024)
4.2 Global Progenitor Cell Product Forecasted Market Size by Type (2025-2030)
5 Progenitor Cell Product Breakdown Data by Application
5.1 Global Progenitor Cell Product Historic Market Size by Application (2019-2024)
5.2 Global Progenitor Cell Product Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Progenitor Cell Product Market Size (2019-2030)
6.2 North America Progenitor Cell Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Progenitor Cell Product Market Size by Country (2019-2024)
6.4 North America Progenitor Cell Product Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Progenitor Cell Product Market Size (2019-2030)
7.2 Europe Progenitor Cell Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Progenitor Cell Product Market Size by Country (2019-2024)
7.4 Europe Progenitor Cell Product Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Progenitor Cell Product Market Size (2019-2030)
8.2 Asia-Pacific Progenitor Cell Product Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Progenitor Cell Product Market Size by Region (2019-2024)
8.4 Asia-Pacific Progenitor Cell Product Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Progenitor Cell Product Market Size (2019-2030)
9.2 Latin America Progenitor Cell Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Progenitor Cell Product Market Size by Country (2019-2024)
9.4 Latin America Progenitor Cell Product Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Progenitor Cell Product Market Size (2019-2030)
10.2 Middle East & Africa Progenitor Cell Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Progenitor Cell Product Market Size by Country (2019-2024)
10.4 Middle East & Africa Progenitor Cell Product Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NeuroNova AB
11.1.1 NeuroNova AB Company Detail
11.1.2 NeuroNova AB Business Overview
11.1.3 NeuroNova AB Progenitor Cell Product Introduction
11.1.4 NeuroNova AB Revenue in Progenitor Cell Product Business (2019-2024)
11.1.5 NeuroNova AB Recent Development
11.2 StemCells
11.2.1 StemCells Company Detail
11.2.2 StemCells Business Overview
11.2.3 StemCells Progenitor Cell Product Introduction
11.2.4 StemCells Revenue in Progenitor Cell Product Business (2019-2024)
11.2.5 StemCells Recent Development
11.3 ReNeuron Limited
11.3.1 ReNeuron Limited Company Detail
11.3.2 ReNeuron Limited Business Overview
11.3.3 ReNeuron Limited Progenitor Cell Product Introduction
11.3.4 ReNeuron Limited Revenue in Progenitor Cell Product Business (2019-2024)
11.3.5 ReNeuron Limited Recent Development
11.4 Asterias Biotherapeutics
11.4.1 Asterias Biotherapeutics Company Detail
11.4.2 Asterias Biotherapeutics Business Overview
11.4.3 Asterias Biotherapeutics Progenitor Cell Product Introduction
11.4.4 Asterias Biotherapeutics Revenue in Progenitor Cell Product Business (2019-2024)
11.4.5 Asterias Biotherapeutics Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Progenitor Cell Product Introduction
11.5.4 Thermo Fisher Scientific Revenue in Progenitor Cell Product Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 STEMCELL Technologies
11.6.1 STEMCELL Technologies Company Detail
11.6.2 STEMCELL Technologies Business Overview
11.6.3 STEMCELL Technologies Progenitor Cell Product Introduction
11.6.4 STEMCELL Technologies Revenue in Progenitor Cell Product Business (2019-2024)
11.6.5 STEMCELL Technologies Recent Development
11.7 Axol Bio
11.7.1 Axol Bio Company Detail
11.7.2 Axol Bio Business Overview
11.7.3 Axol Bio Progenitor Cell Product Introduction
11.7.4 Axol Bio Revenue in Progenitor Cell Product Business (2019-2024)
11.7.5 Axol Bio Recent Development
11.8 R&D Systems
11.8.1 R&D Systems Company Detail
11.8.2 R&D Systems Business Overview
11.8.3 R&D Systems Progenitor Cell Product Introduction
11.8.4 R&D Systems Revenue in Progenitor Cell Product Business (2019-2024)
11.8.5 R&D Systems Recent Development
11.9 Lonza
11.9.1 Lonza Company Detail
11.9.2 Lonza Business Overview
11.9.3 Lonza Progenitor Cell Product Introduction
11.9.4 Lonza Revenue in Progenitor Cell Product Business (2019-2024)
11.9.5 Lonza Recent Development
11.10 ATCC
11.10.1 ATCC Company Detail
11.10.2 ATCC Business Overview
11.10.3 ATCC Progenitor Cell Product Introduction
11.10.4 ATCC Revenue in Progenitor Cell Product Business (2019-2024)
11.10.5 ATCC Recent Development
11.11 Irvine Scientific
11.11.1 Irvine Scientific Company Detail
11.11.2 Irvine Scientific Business Overview
11.11.3 Irvine Scientific Progenitor Cell Product Introduction
11.11.4 Irvine Scientific Revenue in Progenitor Cell Product Business (2019-2024)
11.11.5 Irvine Scientific Recent Development
11.12 CDI
11.12.1 CDI Company Detail
11.12.2 CDI Business Overview
11.12.3 CDI Progenitor Cell Product Introduction
11.12.4 CDI Revenue in Progenitor Cell Product Business (2019-2024)
11.12.5 CDI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
